|
1
|
Age ≥ 18 years
|
|
2
|
Symptomatic osteoarthritis of hip or knee (following the revised criteria of the American College of Rheumatology)
|
|
3
|
Willingness to comply with follow-up assessments and treatment
|
|
4
|
Ability to understand, read and speak German
|
|
Exclusion criteria
|
|
1
|
Endoprothetic replacement of hip or knee joint
|
|
2
|
Inflammatory arthropathy of the hip or the knee
|
|
3
|
Acute, hot, red and swollen knee or hip joint (unknown focus)
|
|
4
|
Inflammatory system diseases which could interfere with the evaluation of the therapy procedure
|
|
5
|
CNS diseases, especially epilepsy
|
|
6
|
Anamnesis of deep vein thrombosis in the past 12 months
|
|
7
|
Severe lung disease such as e.g. COPD stages GOLD III – GOLD IV
|
|
8
|
Heart failure NYHA III – NYHA IV
|
|
9
|
Myocardial ischemia with or without intervention within the last 3 months before inpatient admission
|
|
10
|
Cancer in advanced stage
|
|
11
|
Large skin wounds or inflammatory and ulcerated dermatosis of the legs
|
|
12
|
Severe febrile infectious diseases Non treated hypertension
|
|
13
|
Participation in another clinical study within the past four weeks
|
|
14
|
Pregnancy
|
